Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

LARTRUVO

OLARATUMAB

Standard Dose
500MG/50ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview LARTRUVO is listed in Drugs@FDA under application 761038 (BLA).

Review priority: N/A Marketing status: Prescription Active ingredient OLARATUMAB Form and strength INJECTABLE; INJECTION - 500MG/50ML Sponsor ELI LILLY AND CO Submission history Latest submission status date: 2019-07-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview LARTRUVO is listed in Drugs@FDA under application 761038 (BLA). Review priority: N/A Marketing status: Prescription Active ingredient OLARATUMAB Form and strength INJECTABLE; INJECTION - 500MG/50ML Sponsor ELI LILLY AND CO Submission history Latest submission status date: 2019-07-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.